MANDRUZZATO, SUSANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.675
AS - Asia 4.943
EU - Europa 2.348
AF - Africa 831
SA - Sud America 805
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 36
Totale 17.699
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.228
SG - Singapore 1.449
CN - Cina 943
VN - Vietnam 927
BR - Brasile 483
HK - Hong Kong 461
IT - Italia 421
DE - Germania 283
FI - Finlandia 266
FR - Francia 189
IN - India 161
GB - Regno Unito 127
UA - Ucraina 104
RU - Federazione Russa 94
SE - Svezia 94
PL - Polonia 87
IQ - Iraq 77
NL - Olanda 71
TR - Turchia 71
AR - Argentina 69
CA - Canada 67
BD - Bangladesh 63
SA - Arabia Saudita 58
JP - Giappone 57
MX - Messico 53
PH - Filippine 52
ZA - Sudafrica 50
EC - Ecuador 46
PK - Pakistan 44
AT - Austria 38
ES - Italia 36
ID - Indonesia 36
MA - Marocco 35
CL - Cile 34
IE - Irlanda 34
CO - Colombia 33
UZ - Uzbekistan 33
IL - Israele 32
VE - Venezuela 32
EG - Egitto 30
AE - Emirati Arabi Uniti 28
LY - Libia 28
TN - Tunisia 28
AO - Angola 27
BG - Bulgaria 26
CI - Costa d'Avorio 26
CR - Costa Rica 26
CZ - Repubblica Ceca 26
KE - Kenya 26
UY - Uruguay 26
BO - Bolivia 25
HU - Ungheria 25
KH - Cambogia 25
RE - Reunion 25
UG - Uganda 25
CH - Svizzera 24
GR - Grecia 24
GT - Guatemala 24
JO - Giordania 24
NP - Nepal 24
PS - Palestinian Territory 24
SI - Slovenia 24
ZM - Zambia 24
CG - Congo 23
DK - Danimarca 23
DZ - Algeria 23
ET - Etiopia 23
KG - Kirghizistan 23
KR - Corea 23
LA - Repubblica Popolare Democratica del Laos 23
TJ - Tagikistan 23
AZ - Azerbaigian 22
BE - Belgio 22
HN - Honduras 22
JM - Giamaica 22
PE - Perù 22
PT - Portogallo 22
AM - Armenia 21
BY - Bielorussia 21
GF - Guiana Francese 21
GM - Gambi 21
LU - Lussemburgo 21
YE - Yemen 21
BB - Barbados 20
CV - Capo Verde 20
CY - Cipro 20
EE - Estonia 20
GN - Guinea 20
ME - Montenegro 20
ML - Mali 20
SN - Senegal 20
TH - Thailandia 20
VC - Saint Vincent e Grenadine 20
GH - Ghana 19
HR - Croazia 19
LV - Lettonia 19
MU - Mauritius 19
TT - Trinidad e Tobago 19
YT - Mayotte 19
AL - Albania 18
Totale 16.826
Salva come PNG Salva come JPEG
Città #
Ashburn 966
Singapore 860
Fairfield 791
San Jose 788
Woodbridge 708
Houston 613
Chandler 536
Ann Arbor 503
Hong Kong 412
Wilmington 321
Jacksonville 306
Seattle 302
Ho Chi Minh City 269
Cambridge 265
Beijing 262
Hanoi 215
Helsinki 168
Princeton 141
Boardman 131
Santa Clara 128
Los Angeles 104
Lauterbourg 94
San Diego 89
Padova 88
New York 76
Da Nang 70
Des Moines 61
Roxbury 61
Council Bluffs 57
Nanjing 53
Bytom 52
Medford 50
Dong Ket 46
Milan 46
Munich 45
São Paulo 45
Haiphong 37
Baghdad 35
Chicago 35
Orem 33
London 32
Tashkent 31
Tokyo 30
Frankfurt am Main 29
Guangzhou 29
Jeddah 28
Abidjan 26
Buffalo 26
Dublin 26
Johannesburg 25
Kampala 25
Nairobi 25
Amman 24
Lusaka 24
Montevideo 23
Phnom Penh 23
Dushanbe 22
Istanbul 22
Montreal 22
Vienna 22
Vientiane 22
Dallas 21
Quito 21
San José 21
Baku 20
Conakry 20
Dakar 20
Kingstown 20
Luanda 20
Addis Ababa 19
Bamako 19
Bridgetown 19
Rome 19
Shenyang 19
Bishkek 18
Podgorica 18
Riga 18
Andorra la Vella 17
Atlanta 17
Brooklyn 17
Chennai 17
Hefei 17
Hải Dương 17
Kingston 17
Panama City 17
Yerevan 17
Antananarivo 16
Dili 16
Nanchang 16
Nuremberg 16
Praia 16
Tripoli 16
Warsaw 16
Accra 15
Biên Hòa 15
Brasília 15
Casablanca 15
Jiaxing 15
Kigali 15
Libreville 15
Totale 11.080
Salva come PNG Salva come JPEG
Nome #
Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression 386
Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. 385
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells 313
Clinical implication of tumor-associated and immunological parameters in melanoma patients treated with ipilimumab 308
Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy 307
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 300
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 285
The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion. 274
Complexity and challenges in defining myeloid-derived suppressor cells. 261
Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma 252
Dissecting the molecular regulatory networks in human myeloid-derived suppressor cells 251
Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study 248
In Brief: Myeloid-derived suppressor cells in cancer 247
Human MDSCs derived from the bone marrow maintain their functional ability but have a reduced frequency of induction in the elderly compared to pediatric donors 238
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression 236
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 236
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study 236
Myeloid Diagnostic and Prognostic Markers of Immune Suppression in the Blood of Glioma Patients 230
Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area 226
Cancer rejection by the immune system: forcing the check-points of tumor immune escape. 221
A gene expression signature associated with survival in metastatic melanoma 219
Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules 217
Methods to Measure MDSC Immune Suppressive Activity In Vitro and In Vivo 214
Myeloid cell diversification and complexity: an old concept with new turns in oncology. 210
An integrative framework identifies alternative splicing events in colorectal cancer development. 210
Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities 209
Antigen specificity of immune suppression by myeloid-derived suppressor cells. 209
Exocytosis of azurophil and arginase 1-containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation 207
Common cancer biomarkers 207
Human miRNome profiling in colorectal cancer and liver metastasis development 203
Highlights on molecular mechanisms of MDSC-mediated immune suppression: paving the way for new working hypotheses. 201
Melanoma-restricted genes 197
Magnetic Resonance Imaging Correlates of Immune Microenvironment in Glioblastoma 196
Reprogramming T Lymphocytes for Melanoma Adoptive Immunotherapy by T-Cell Receptor Gene Transfer with Lentiviral Vectors 193
Longitudinal evolution of the immune suppressive glioma microenvironment in different synchronous lesions during treatment 192
The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumors 191
ANTITUMOR EFFICACY OF LYMPHOKINE-ACTIVATED KILLER-CELLS LOADED WITH RICIN AGAINST EXPERIMENTALLY INDUCED LUNG METASTASES 190
Myeloid derived suppressor cells in the crosstalk between COPD and lung cancer 190
Sustained accumulation of blood‐derived macrophages in the immune microenvironment of patients with recurrent glioblastoma after therapy 190
Myeloid-derived suppressor cell heterogeneity in human cancers. 188
The immunosuppression pathway of tumor-associated macrophages is controlled by heme oxygenase-1 in glioblastoma patients 185
MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas 184
IL4R alpha(+) Myeloid-Derived Suppressor Cell Expansion in Cancer Patients 183
ADOPTIVE TRANSFER OF LYMPHOKINE-ACTIVATED KILLER-CELLS LOADED WITH 4'-DEOXY-4'-IODODOXORUBICIN - THERAPEUTIC EFFECT IN MICE BEARING LUNG METASTASES 181
Part II: Vaccines for haematological malignant disorders 180
Correction to: Human MDSCs derived from the bone marrow maintain their functional ability but have a reduced frequency of induction in the elderly compared to pediatric donors (Immunity & Ageing, (2020), 17, 1, (27), 10.1186/s12979-020-00199-5) 180
Identification of genes selectively regulated by IFNs in endothelial cells 176
GM-CSF and IL-6 induce tolerogenic myeloid-derived suppressor cells through C/EBP beta and allow long term islet allograft survival 176
CD45 regulates apoptosis induced by extracellular adenosine triphosphate and cytotoxic T lymphocytes 171
Protein tyrosine kinases and phosphatases control apoptosis induced by extracellular adenosine 5'-triphosphate. 171
Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma 170
Sodium fluorescein uptake by the tumor microenvironment in human gliomas and brain metastases 169
INHIBITION OF PROTEIN-TYROSINE PHOSPHORYLATION PREVENTS T-CELL-MEDIATED CYTOTOXICITY 169
Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPbeta Transcription Factor. 168
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards 166
Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: A novel target for therapeutic intervention 165
Myeloid-derived suppressor cell heterogeneity and subset definition 165
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. 164
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. 163
Tumor-induced myeloid deviation: When myeloid-derived suppressor cells meet tumor-Associated macrophages 162
Upregulation of myeloid derived suppressor cells (MDSCs) in chronic obstructive pulmonary disease and its relationship with disease severity 162
Arginase, Nitric Oxide Synthase, and Novel Inhibitors of L-Arginine Metabolism in Immune Modulation 162
Technological platforms for microarray gene expression profiling 161
Synergistic effect of extracellular adenosine 5-triphosphate and tumor necrosis factor on DNA degradation 157
Human fibrocytic myeloid-derived suppressor cells express IDO and promote tolerance via Treg-cell expansion 152
Role of anti-LFA-1 and anti-ICAM-1 combined mAb treatment in the rejection of tumors induced by Moloney murine sarcoma virus (M-MSV) 149
Inhibition of CTLI-line lysis after gangliosides treatment 148
A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. 147
Large and dissimilar repertoire of Melan-A/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient 147
Differential expression of constitutive and inducible proteasome subunits in human monocyte-derived DC differentiated in the presence of IFN-alpha or IL-4 146
MAGE, BAGE, and GAGE overexpression in patients with esophageal squamous cell carcinoma and adenocarcinoma of gastric cardia 145
Part I: Vaccines for solid tumours 142
Antitumors DNA vaccines [Vaccini antitumorali a DNA] 139
Cancer vaccines: pessimism in check 137
THE INVIVO ROLE OF LEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 IN CYTOTOXIC-CELL ACTIVITY AGAINST TUMORS INDUCED BY MOLONEY-MURINE SARCOMA LEUKEMIA RETROVIRAL COMPLEX 136
Therapeutical effect of 4′-deoxy-4′-iododoxorubicin-loaded LAK cells in mice bearing lung metastases 135
Drug-loaded nanoparticles induce immunogenic cell death and efficiently target cells from glioblastoma patients 134
Myeloid-derived Suppressor Cells in Cancer Patients: A Clinical Perspective. 134
Transcriptomic profiling of cytomegalovirus infection in cardiac transplantation: proof-of-concept for a new strategy in tissue markers application 133
ROLE OF ADHESION MOLECULES IN THE IMMUNE-REACTION TO M-MSV-INDUCED TUMORS 133
From medical to biological informatics: Searching for diagnostic markers in Parkinson's disease patients' lymphocytes using transcriptomics 132
Assessing and Countering Negative Immune Regulation in Renal Cell Cancer Patients-Results of a Randomized Phase II Trial with IMA901 132
Metastatic Lesions with and without Interleukin-18-Dependent Genes in Advanced-Stage Melanoma Patients. 131
Role of CD45 PTP in CTL-mediated apoptosis 130
Vaccines for solid tumours (vol 5, pg 681, 2004) 129
Interaction of large granular lymphocytes with susceptible target does not induce second messanger and cytolytic granule exocitosis 128
A human CTL recognizes a caspase-8-derived peptide on autologous HLA-B*3503 molecules and two unrelated peptides on allogeneic HLA-B*3501 molecules 128
USE OF MYELOID CELL BIOMARKERS FOR THE DIAGNOSIS OF CANCER - N. US2012070461 123
Gene expression profile of cerebrospinal fluid mononuclear cells in oligoclonal band positive and oligoclonal band negative multiple sclerosis patients at early stage of disease 115
Lymph Node Metastatic fingerprint revealed by genome-Wide transcriptional profiling of primary breast cancer. 114
Editorial: Novel roles for tumor-associated neutrophils 113
Study On Intracellular Signals Involved In the Induction of Programmed Cell Death 111
Lymph node metastatic fingerprint revealed by genome-wide transcriptional profiling of primary breast cancer 104
ROLE OF TYROSINE-KINASES AND PHOSPHATASES IN PROGRAMMED CELL-DEATH 102
Myeloid-derived suppressor cells generated in vitro 92
Letter to the Editor Regarding "5-Aminolevulinic Acid False Positives in Cerebral Neuro-Oncology: Not All That Is Fluorescent Is Tumor. A Case-Based Update and Literature Review" 88
ZnPPIX-Loaded Nanoemulsions Reprogram Immunosuppressive Macrophages in Vitro: A Potential Strategy for Glioblastoma Microenvironment Modulation 56
Editorial: Roles of macrophages and monocytes in resistance to immunotherapy in cancers 26
Totale 17.774
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.576
article - articoli 46.092
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 499
selected - selezionate 0
volume - volumi 497
Totale 96.664
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021189 0 0 0 0 0 0 0 0 0 0 108 81
2021/20221.207 24 143 125 96 36 74 82 122 58 40 133 274
2022/20231.007 221 121 29 115 148 117 10 64 116 16 41 9
2023/2024529 16 60 96 41 53 52 61 19 19 9 49 54
2024/20252.031 16 108 88 61 279 89 93 173 225 88 328 483
2025/20268.791 367 692 1.184 1.442 769 418 1.391 820 967 522 219 0
Totale 17.774